Tissue Biopsies: US FDA Urges Careful Balance Of Risk v Need In Clinical Trials

In new draft guidance, the US FDA recommends sponsors carefully weigh the circumstances for requiring tissue biopsies for clinical trial subjects and emphasizes the need to limit them in pediatric studies.